ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Crown Bioscience, Inc.
The Research Associate at Crown Bioscience North Carolina supports in vivo research studies in oncology and pharmacology, working closely with scientific teams to conduct experiments, maintain animal models, and analyze data, contributing to preclinical research quality and integrity.
Headquarters
San Diego, California, United States
Company Size
1001-5000 employees
Founded
2006
N/A
NaturePreclinical evidence for the effective use of TL-895, a highly selective and potent second-generation BTK inhibitor, for the treatment of B-cell malignancies
Nov 21, 2023
NatureNarazaciclib, a novel multi-kinase inhibitor with potent activity against CSF1R, FLT3 and CDK6, shows strong anti-AML activity in defined preclinical models
Apr 19, 2024
NatureComparison of Continuous Glucose Monitoring between Dexcom G4 Platinum and HD-XG Systems in Nonhuman Primates ( Macaca Fascicularis
Aug 29, 2017
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Crown Bioscience, Inc..
29% below the average for this role
Senior Research Associate, In Vivo Pharmacology
Astellas
Senior Scientist II
Exelixis
In Vivo Pharmacology Sr. Associate Scientist
Pfizer
Senior Research Associate I/II – In Vivo
Monte Rosa Therapeutics, Inc
Research Scientist, in vivo Pharmacology-Oncology
Novartis
Senior Scientist – In Vivo Pharmacology, Oncology R&D
AstraZeneca